Atypical polyarticular juvenile idiopathic arthritis revealing multicentric reticulohistiocytosis with pulmonary involvement
- 5 September 2022
- journal article
- letter
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 62 (4) , e122-e123
Abstract
Dear Editor, Multicentric reticulohistiocytosis (MRH) is a rare systemic disease affecting mainly adults and most frequently associating joint and skin involvement. Other rare organ involvement should be investigated. Here, we report the first case of MRH in an adolescent with a pulmonary involvement. A 13-year-old boy was admitted with wrist and metacarpophalangeal arthritis associated with Achilles tendon enthesitis. The first diagnosis was enthesitis-related JIA in the absence of psoriasis. He had no family history of rheumatological or digestive conditions. Initial blood tests did not show any abnormal acute phase reactant levels, blood cell counts were normal, ANA titres were positive at 1/160, and HLA-B27 and rheumatoid factor findings were negative. From disease onset, he had multiple non-itchy nodules over the extension face of the elbows ( Fig. 1A). He started a first treatment with non-steroidal anti-inflammatory drugs and MTX with initial efficacy on joints. After 9 months of treatment, he had a relapse, with polyarthritis affecting the small joints of the hands but without enthesitis. New lab tests revealed positivity for rheumatoid factor at 477 UI/ml and eosinophilia count up to 1.5 G/l. A new diagnosis was polyarticular JIA. He started treatment with adalimumab associated with MTX, which led to an amelioration of the arthritis. After 10 months of this treatment, the boy had a relapse again, which led to a further change in therapy to etanercept and MTX. Etanercept was quickly stopped because of an allergic reaction in the form of a painful skin rash and was replaced with intravenous tocilizumab. Unfortunately, this treatment was insufficient and led to further arthritis, joint deformities ( Fig. 1B), fatigue and weight loss. The boy then received intravenous abatacept. With these different biotherapies, many infections appeared, such as septic arthritis, appendicitis and herpes zoster. The work-up including complete blood count, immunoglobulin levels, vaccine titres and immunophenotyping remained normal. We finally performed a biopsy of the persistent skin nodules, which revealed dermal histiocytic proliferation positive for CD68 and CD163 and negative for CD1a and PS100 on immunohistochemical staining associated with multinucleated giant cells. These histological features then allowed for the diagnosis of MRH. A new extensive work-up showed a mild biological inflammation (erythrocyte sedimentation rate 54 mm/h and CRP level 15 mg/l). Chest CT revealed non-specific interstitial lung disease with a cluster of subpleural honeycomb cysts, diffuse ill-defined centrilobular micronodules, ground-glass opacities and reticulation ( Fig. 1C–E). Respiratory function tests showed a moderate restrictive syndrome. Cardiac ultrasonography gave normal results, as did fluorodeoxyglucose-PET/CT. Repeated ophthalmological examinations from the beginning of the disease were all normal. We concluded a diagnosis of MRH with skin, joint and lung involvement. The boy started treatment with infliximab associated with MTX, corticosteroids and bisphosphonates (zoledronate). After 6 months’ follow-up, he was in complete joint remission, and corticosteroids were gradually reduced to a dose of 0.1 mg/kg/day. Chest CT showed a disappearance of the micronodules. Skin lesions decreased in size, with healing of excoriated nodules.Keywords
This publication has 8 references indexed in Scilit:
- Multicentric reticulohistiocytosis associated with organizing pneumoniaJoint Bone Spine, 2021
- Multicentric reticulohistiocytosis: the Mayo Clinic experience (1980–2017)Rheumatology, 2019
- Organizing pneumonia associated with multicentric reticulohistiocytosisRespirology Case Reports, 2015
- Multicentric Reticulohistiocytosis: a Critical ReviewCurrent Rheumatology Reports, 2015
- Multicentric ReticulohistiocytosisArchives of Dermatology, 2012
- Multicentric reticulohistiocytosis with lungs and liver involvedClinical and Experimental Dermatology, 2009
- Multicentric Reticulohistiocytosis Successfully Treated With InfliximabArchives of Dermatology, 2008
- Multicentric reticulohistiocytosis with pulmonary involvementJournal of the American Academy of Dermatology, 2003